Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.51 |
| ▸ | IDO1 | P14902 | 3/20 | 0.45 |
| ▸ | PNMT | P11086 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 2/20 | 0.39 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6480647 | 0.84 | TDP1 (0.45) | TAAR1MEN1TP53CYP3A4KMT2A | |
| SCHEMBL29826970 | 0.84 | TDP1 (0.45) | TAAR1MEN1TP53CYP3A4KMT2A | |
| SCHEMBL28859704 | 0.82 | TAAR1 (0.37) | TAAR1PNMTKDM4EHTTCYP2A13 | |
| SCHEMBL13116361 | 0.81 | HSP90AA1 (0.45) | TAAR1PNMTCYP2A13MEN1TP53 | |
| SCHEMBL31076452 | 0.81 | TAAR1 (0.36) | TAAR1IDO1PNMTKDM4EHTT | |
| SCHEMBL11455975 | 0.80 | TAAR1 (0.48) | TAAR1IDO1PNMTKDM4EHTT | |
| SCHEMBL2675606 | 0.78 | TDP1 (0.41) | TAAR1MEN1TP53CYP3A4CYP2C9 | |
| SCHEMBL28454337 | 0.78 | TDP1 (0.41) | TAAR1MEN1TP53CYP3A4KMT2A | |
| SCHEMBL30607492 | 0.78 | TDP1 (0.41) | TAAR1MEN1TP53CYP3A4KMT2A | |
| SCHEMBL11075952 | 0.78 | KMT2A (0.49) | TAAR1IDO1PNMTKDM4EHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3762369-B1 | A PROCESS FOR PREPARATION OF FUNGICIDALLY ACTIVE TRIAZOLE COMPOUNDS | UPL LTD (IN) | 2024-12-11 | — | — | EP | disclosed |
| CN-117126044-B | Microwave-assisted synthesis method of methyl ketone compound | 延边大学 | 2024-01-26 | — | — | CN | disclosed |
| CN-117126044-A | Microwave-assisted synthesis method of methyl ketone compound | 延边大学 | 2023-11-28 | — | — | CN | disclosed |
| US-11634394-B2 | Process for preparation of fungicidally active triazole compounds | UPL LTD (IN) | 2023-04-25 | — | — | US | disclosed |
| US-20220089552-A1 | PROCESS FOR PREPARATION OF FUNGICIDALLY ACTIVE TRIAZOLE COMPOUNDS | UPL LTD (IN) | 2022-03-24 | — | — | US | disclosed |
| US-7642277-B2 | Non-nucleoside reverse transcriptase inhibitors | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2010-01-05 | — | — | US | disclosed |
| US-7642277-B2 | Non-nucleoside reverse transcriptase inhibitors | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2010-01-05 | — | — | US | disclosed |
| US-7642277-B2 | Non-nucleoside reverse transcriptase inhibitors | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2010-01-05 | — | — | US | disclosed |
| EP-1569919-A2 | NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS | Boehringer Ingelheim International GmbH (DE) | 2005-09-07 | — | — | EP | disclosed |
| US-20050054639-A1 | Non-nucleoside reverse transcriptase inhibitors | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2005-03-10 | — | — | US | disclosed |
| WO-2004050643-A2 | NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2004-06-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11634394-B2 | Process for preparation of fungicidally active triazole compounds | CAT, TYR, TH | TAAR1 267/4885IDO1 993/4885PNMT 123/4885 |
| US-20050054639-A1 | Non-nucleoside reverse transcriptase inhibitors | NAT1, SUB1, RTF2 | TAAR1 1196/4885IDO1 304/4885PNMT 917/4885 |
| US-20220089552-A1 | PROCESS FOR PREPARATION OF FUNGICIDALLY ACTIVE TRIAZOLE COMPOUNDS | CAT, TYR, TH | TAAR1 267/4885IDO1 993/4885PNMT 123/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.